Exelerate Capital Corp.
TTSXV:XCAP.P0.04
CAD
+0.00
(-12.50%)
ISIN
CA30163L1031
CUSIP
30163L103
Return %
Stock
S&P 500
1Y
-22.22
14.20
3Y
-12.50
81.12
5Y
-84.78
68.34
Capital Structure
CAD
•
in mil. unless spec.Working Capital
CAD
•
in mil. unless spec.Growth Rates
CAD
•
in mil. unless spec.Quarterly Revenue
CAD
•
in mil. unless spec.Quarterly Earnings Per Share
CAD
•
in mil. unless spec.Quarterly Dividends Per Share
CAD
•
in mil. unless spec.Company Description
- CEO
- Mark William Kohler
- Sector
- Finance
- Industry
- Financial conglomerates
- Address
- Vancouver Canada
- IPO Date
- Jun 7, 2019
- Similar Companies
- Business
- Exelerate Capital Corp. is a Canada-based capital pool company focused on identifying, evaluating, and negotiating the acquisition of assets or operating businesses with the objective of completing a Qualifying Transaction pursuant to Policy 2.4 of the TSX Venture Exchange. The company does not maintain active commercial or manufacturing operations, directing its core business activities toward corporate finance and public listing execution services, which include: target identification and proprietary business screening; technical, financial, and legal due diligence; transaction structuring and equity financing coordination; regulatory compliance and public market disclosure management; and reverse takeover execution and public listing transition support. Founded in 2018 and headquartered in Vancouver, British Columbia, Canada, the company operates within the Canadian capital markets to source target business entities across diverse commercial and industrial sectors. In major corporate developments, the company completed a strategic corporate reorganization and name change from Exelerate Health Inc. to Exelerate Capital Corp. to broaden its acquisition mandate beyond healthcare, transitioned its corporate governance framework under the amended TSX Venture Exchange Capital Pool Company policies to enhance capital deployment flexibility, and continues the ongoing screening and evaluation of prospective acquisition targets to facilitate its transition to a commercial operating issuer on the TSX Venture Exchange.